Eleni Aklillu

ORCID, self-asserted

ORCID 0000-0002-9788-0790

Publications

Citations

321

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

7 works in the graph, newest first.

Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines
2026The Lancet MicrobeJournalOpen access2 citations10.1016/j.lanmic.2026.101442
Widespread Variants of the Highly Polymorphic Plasmodium falciparum Vaccine Candidate Antigen MSP2 Across Sub-Saharan Africa
2026The Journal of Infectious DiseasesJournalOpen access0 citations10.1093/infdis/jiag377
Malaria resurgence in Africa: confronting the challenges
2025The Lancet Infectious DiseasesJournal3 citations10.1016/s1473-3099(25)00499-2
Overcoming the global tuberculosis crisis with urgent country-level political and financial action
2024The Lancet Infectious DiseasesJournal9 citations10.1016/s1473-3099(24)00748-5
End of the Bedaquiline patent – a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries
2023International Journal of Infectious DiseasesJournalOpen accessCorresponding4 citations10.1016/j.ijid.2023.04.386
World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis
2022The Lancet Infectious DiseasesJournalOpen access21 citations10.1016/s1473-3099(22)00142-6
Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.
2022International Journal of Infectious DiseasesJournalOpen access5 citations10.1016/j.ijid.2022.03.012